ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
TD Canadian Equity Index ETF

TD Canadian Equity Index ETF (TTP)

28.48
-0.14
(-0.49%)
Cerrado 17 Noviembre 3:12PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
28.48
Postura de Compra
28.46
Postura de Venta
28.48
Volume Operado de la Acción
33,312
28.39 Rango del Día 28.59
0.00 Rango de 52 semanas 0.00
Precio Anterior
28.62
Precio de Apertura
28.55
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

TTP Últimas noticias

Titan Pharmaceuticals Announces That Novartis Licenses Iloperidone To Vanda Pharmaceuticals

Titan Pharmaceuticals Announces That Novartis Licenses Iloperidone To Vanda Pharmaceuticals Vanda to Complete Iloperidone Development SOUTH SAN FRANCISCO, Calif., June 9 /PRNewswire-FirstCall/...

Titan Initiates Phase II Clinical Studies of Pivanex(R) in Leukemia and Melanoma

Titan Initiates Phase II Clinical Studies of Pivanex(R) in Leukemia and Melanoma Patient Enrollment in Randomized Phase IIb Study in Lung Cancer Complete SOUTH SAN FRANCISCO, Calif., May 24...

Titan Announces Pivanex(R) Is Active Against Cancer-Related Genes

Titan Announces Pivanex(R) Is Active Against Cancer-Related Genes Data presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics SOUTH SAN FRANCISCO...

Titan Reports Third Quarter 2003 Results

Titan Reports Third Quarter 2003 Results SOUTH SAN FRANCISCO, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. today reported financial results for the third quarter and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CEROCERo Therapeutics Holdings Inc
US$ 0.2853
(52.40%)
1.15B
CYCNCyclerion Therapeutics Inc
US$ 2.5306
(42.97%)
11.99M
SPPLSIMPPLE Ltd
US$ 1.2503
(41.60%)
164.49M
PULMPulmatrix Inc
US$ 6.5586
(39.54%)
5.31M
ZTEKZentek Ltd
US$ 1.2574
(29.96%)
308.63k
TFFPTFF Pharmaceuticals Inc
US$ 0.376101
(-76.49%)
9.23M
EYENEyenovia Inc
US$ 0.10185
(-70.05%)
51.98M
CTXRCitius Pharmaceuticals Inc
US$ 0.1974
(-39.89%)
11.15M
VVPRVivoPower International PLC
US$ 0.8151
(-39.62%)
2.3M
IPWiPower Inc
US$ 0.7302
(-39.15%)
1.13M
CEROCERo Therapeutics Holdings Inc
US$ 0.2853
(52.40%)
1.15B
ELABElevai Labs Inc
US$ 0.0211
(-19.47%)
377.69M
NVDANVIDIA Corporation
US$ 141.98
(-3.26%)
244.07M
SPPLSIMPPLE Ltd
US$ 1.2503
(41.60%)
164.49M
STISolidion Technology Inc
US$ 0.44
(25.71%)
139.46M
rooster rooster 3 minutos hace
Everyone loves Trump! https://x.com/boloudon/status/1857983446724849892?s=46&t=qLQnO1TjeygtFbhEqQdlmg
The Night Stalker The Night Stalker 3 minutos hace
solid hold
MAJI
The Night Stalker The Night Stalker 5 minutos hace
gem.......
ACGX
rooster rooster 6 minutos hace
https://x.com/charliekirk11/status/1857989857122963462?s=46&t=qLQnO1TjeygtFbhEqQdlmg
lakers17 lakers17 8 minutos hace
Total BS. This receiver was a smart guy and had total knowledge of the situation and crypto and the value of what NSAV had which is clearly worthless as a real tangible asset. It's actually you who obviously know nothing about crypto and how it really works. So I ask again how much crypto do you
NSAV
The Night Stalker The Night Stalker 11 minutos hace
https://www.stockscores.com/charts/charts/?ticker=mdtc
MDTC
RealDutch RealDutch 13 minutos hace
They met with the bank on saturday. They will give an update shortly.
ITUP
dstock07734 dstock07734 17 minutos hace
Absolutely!

It is obvious that there will be no BO from Merck.
NWBO
doc063 doc063 18 minutos hace
I'm feeling good because I took some profits. ;-
XRPUSD
BDEZ BDEZ 18 minutos hace
Exactly DT, who is going to put their foot down???
BDEZ BDEZ 19 minutos hace
Biden, Harris Raided Medicare to Fund Green New Deal

https://x.com/DefiyantlyFree/status/1857264348210557058?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1857264348210557058%7Ctwgr%5Ee15f8b43a0bcb7da4c0c4fee504b9bb629016812%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fwww.thegatewaypun
karlacorn3 karlacorn3 21 minutos hace
Wondering if this info is to be received as stated on the 15th.
Respectfully,
K Likewise, I will be circulating to the shareholders tomorrow, of our payment resolution and the tentative date we would be making the cash grant payout -- we will not go blank for sure,

Than
ITUP
StockItOut StockItOut 22 minutos hace
There is proof in XTI-and-XTIA filings that XTI-issued-XTI-stock-to-Xeriant. Some still won't accept that fact.
XTIA
rosemountbomber rosemountbomber 23 minutos hace
Thanks for all that insight Kiwi.  Have to assume Mott knows something about the path they will take going forward. I would feel better if the Kidney Act passed Congress. . 
ARDX
Moonboy1 Moonboy1 29 minutos hace
That's a pretty significant dump after the pump.
XRPUSD
ipiros ipiros 32 minutos hace
https://www.euniex.com/en/expertos

There is our Antonio!
IGEX
leverage102 leverage102 34 minutos hace
Receiver couldn't computate tokens. 2nd Quarter earnings / Token valuations were Posted after the receiver was on board.

* There is no complaint made, NO IT WILL NOT BE A PRIORITY. * Plus this is the OTC PINK; hence companies work under different rules.

Once compl
NSAV
DTGoody DTGoody 37 minutos hace
Woke TikTok Is LOSING IT Over Trump's Election

https://youtu.be/g5Vh7UzCLqM
TomD2046 TomD2046 38 minutos hace
New filing in Nevada on Nov 15th. Don't know how to insert pics here. Check out sos site https://esos.nv.gov/EntitySearch/BusinessFilingHistoryOnline
FBEC
dstock07734 dstock07734 41 minutos hace
Did FDA approve the combo trial which adopted completely disruptive outcome measures never chosen by any clinical trials on cancer? Would Rosewell review p3 trial data before striking the deal with NWBO?

But nothing is as important as the fundamental question: was massive and sustaina
NWBO
axelvento axelvento 42 minutos hace
Bears need to take into consideration the CMV data coming our this quarter. It's a 3-5 TAM drug with no competitors
I'd be careful shorting this right now!
MRNA